AR024968A1 - Compuestos de oxazolidinona, metodos de preparacion y composicion que los contiene - Google Patents

Compuestos de oxazolidinona, metodos de preparacion y composicion que los contiene

Info

Publication number
AR024968A1
AR024968A1 ARP000103894A ARP000103894A AR024968A1 AR 024968 A1 AR024968 A1 AR 024968A1 AR P000103894 A ARP000103894 A AR P000103894A AR P000103894 A ARP000103894 A AR P000103894A AR 024968 A1 AR024968 A1 AR 024968A1
Authority
AR
Argentina
Prior art keywords
nrc
heteroaryl
aryl
alkyl
oxazolidinones
Prior art date
Application number
ARP000103894A
Other languages
English (en)
Original Assignee
Pharmacia & Upjohn Co Llc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pharmacia & Upjohn Co Llc filed Critical Pharmacia & Upjohn Co Llc
Publication of AR024968A1 publication Critical patent/AR024968A1/es

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D263/00Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
    • C07D263/02Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings
    • C07D263/08Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D263/16Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D263/18Oxygen atoms
    • C07D263/20Oxygen atoms attached in position 2
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/14Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16Anti-Parkinson drugs
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D413/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/10Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing aromatic rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D413/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/12Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D417/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/10Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a carbon chain containing aromatic rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D417/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/12Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Psychology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Plural Heterocyclic Compounds (AREA)

Abstract

Compuestos de formula (1) donde R6 es tioacilo, aminocarbonilo, alcoxicarbonilo, aminotiocarbonilo, alcoxitiocarbonilo, alquiltio(carbonil), o alquiltio(tiocarbonil);R7 es arilo o heteroarilo; R8 es alquilo de C1-7, alquenilo de C1-7, alquinilo de C1-7, NR, O, S, C(=O)NR, NRC(=O), C(=O), C(=O)O, OC(=O), OC(=O)NR, NRC(=O)O, C(=S)NR, NRS(=O), C(=S), C(=S)O, OC(=S), OC(=S)NR, NRC(=S)O, S(=O), SO2, SO2NR, NRSO2, NRCONR, NRC(=S)NNR, o (CH2)nO, donde n = 0-6, y donde Ry R son independientemente H, alquilo, heteroalquilo, arilo, o heteroarilo, y R9 es hidrogeno, OH, OR, SR, NRR, alquilo, arilo, heteroalquilo oheteroarilo, y donde R y R son independientemente H, alquilo, heteroalquilo, arilo o heteroarilo. Se proporcionan oxazolidinonas y métodos para sussíntesis . Además se proporcionan métodos para preparar oxazolidinonas biologicamente activas así como también composiciones farmacéuticamente aceptables quecomprenden oxazolidinonas. Las oxazolidinonas como se revelan en la presente se puedensintetizar fácilmente y se usan en una variedad de aplicacionesincluyendo el uso como agentes antimicrobianos. En una realizacion, se proporciona una variedad de tioamidometiloxazolidinonas y métodos para sus síntesis.
ARP000103894A 1999-07-28 2000-07-27 Compuestos de oxazolidinona, metodos de preparacion y composicion que los contiene AR024968A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US14601299P 1999-07-28 1999-07-28

Publications (1)

Publication Number Publication Date
AR024968A1 true AR024968A1 (es) 2002-10-30

Family

ID=22515530

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP000103894A AR024968A1 (es) 1999-07-28 2000-07-27 Compuestos de oxazolidinona, metodos de preparacion y composicion que los contiene

Country Status (13)

Country Link
US (2) US6441005B1 (es)
EP (1) EP1200416A1 (es)
JP (1) JP2003513885A (es)
KR (1) KR20020022787A (es)
CN (1) CN1367780A (es)
AR (1) AR024968A1 (es)
AU (1) AU773359B2 (es)
BR (1) BR0012742A (es)
CA (1) CA2374383A1 (es)
IL (1) IL147503A0 (es)
MX (1) MXPA02000985A (es)
NZ (1) NZ516853A (es)
WO (1) WO2001009107A1 (es)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7002020B1 (en) * 1998-01-23 2006-02-21 Pharmacia & Upjohn Company Oxazolidinone combinatorial libraries, compositions and methods of preparation
EP1200416A1 (en) * 1999-07-28 2002-05-02 Pharmacia & Upjohn Company Oxazolidinones and their use as antiinfectives
ES2256318T3 (es) * 2000-10-17 2006-07-16 PHARMACIA & UPJOHN COMPANY LLC Metodos de produccion de compuestos de oxazolidinona.
YU52403A (sh) 2000-12-26 2006-03-03 Dr.Reddy's Research Foundation Heterociklična jedinjenja koja imaju antibakterijsko dejstvo, postupak za njihovo dobijanje i farmaceutske smeše koje ih sadrže
US7160912B2 (en) 2000-12-26 2007-01-09 Dr.Reddy's Laboratories Ltd. Heterocyclic compounds having antibacterial activity: process for their preparation and pharmaceutical compositions containing them
WO2003031443A1 (en) 2001-10-04 2003-04-17 Morphochem Aktiengesellschaft für kombinatorische Chemie Dual actions antibiotics comprising a oxazoldinone and a quinolone or naphthyridinone moiety
US6914058B2 (en) * 2002-01-18 2005-07-05 Dr. Reddy's Laboratories, Limited Antibacterial compounds: process for their preparation and pharmaceutical compositions containing them
AU2002339721A1 (en) 2002-09-20 2004-04-08 Lupin Limited Oxazolidinone derivatives, process for their preperation and their use as antimycobacterial agents
AU2002357561A1 (en) * 2002-12-30 2004-07-22 Nanjing Chang'ao Pharmaceutical Science And Technology Limited Company Oxazolidine derivative, methods of preparation and uses
US7144911B2 (en) * 2002-12-31 2006-12-05 Deciphera Pharmaceuticals Llc Anti-inflammatory medicaments
MXPA05011654A (es) 2003-04-30 2005-12-15 Morphochem Ag Komb Chemie Uso de antibioticos hibridos de oxazolidinona-quinolina para el tratamiento del antrax y de otras infecciones.
WO2004101552A1 (en) * 2003-05-14 2004-11-25 Orchid Chemicals & Pharmaceuticals Ltd Oxazolidinone derivatives as antibacterial agents
US8324398B2 (en) * 2003-06-03 2012-12-04 Rib-X Pharmaceuticals, Inc. Process for the synthesis of biaryl oxazolidinones
TWI378092B (en) 2003-06-03 2012-12-01 Rib X Pharmaceuticals Inc Biaryl heterocyclic compounds and methods of making and using the same
DE10340485B4 (de) * 2003-09-03 2015-05-13 Morphochem AG Aktiengesellschaft für kombinatorische Chemie Verfahren zur Herstellung von Oxazolidinon-Chinolon Hybriden
US7687627B2 (en) * 2003-09-08 2010-03-30 Wockhardt Limited Substituted piperidino phenyloxazolidinones having antimicrobial activity with improved in vivo efficacy
WO2005061468A1 (en) * 2003-12-17 2005-07-07 Rib-X Pharmaceuticals, Inc. Halogenated biaryl heterocyclic compounds and methods of making and using the same
PL1709044T5 (pl) 2003-12-18 2014-03-31 Morphochem Aktiengesellschaft Fuer Komb Chemie Antybiotyki hybrydowe oksazolidynon-chinolon
US8158797B2 (en) 2003-12-18 2012-04-17 Morphochem Aktiengesellschaft Fur Kombinatorische Chemie Oxazolidinone-quinolone hybrid antibiotics
ATE496914T1 (de) 2005-06-08 2011-02-15 Rib X Pharmaceuticals Inc Verfahren zur synthese von triazolen
EP2181993A1 (en) * 2006-03-31 2010-05-05 Research Foundation Itsuu Laboratory Antimicrobial oxazolidinone derivatives
CN100395270C (zh) * 2006-05-25 2008-06-18 湖北大学 线型聚苯乙烯支载的(4s)-5,5-二取代基噁唑烷酮及其制备方法和用途
JPWO2009044777A1 (ja) 2007-10-02 2011-02-10 財団法人乙卯研究所 7員ヘテロ環を有するオキサゾリジノン誘導体
CA2929787C (en) 2015-05-12 2021-09-14 The Toronto-Dominion Bank Resource allocation control based on connected devices
CN113018506B (zh) * 2021-03-19 2021-11-30 衡阳市建衡实业有限公司 一种复合聚丙烯酰胺水凝胶及其制备方法

Family Cites Families (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4705799A (en) 1983-06-07 1987-11-10 E. I. Du Pont De Nemours And Company Aminomethyl oxooxazolidinyl benzenes useful as antibacterial agents
DE3884563T2 (de) 1987-10-21 1994-02-17 Du Pont Merck Pharma Aminomethyl-oxo-oxazolidinyl-ethenylbenzen-Derivate, nützlich als antibakterielles Mittel.
US4977173A (en) 1987-10-21 1990-12-11 E. I. Du Pont De Nemours And Company Aminomethyl oxooxazolidinyl ethenylbenzene derivatives useful as antibacterial agents
US4948801A (en) 1988-07-29 1990-08-14 E. I. Du Pont De Nemours And Company Aminomethyloxooxazolidinyl arylbenzene derivatives useful as antibacterial agents
US5225565A (en) 1988-09-15 1993-07-06 The Upjohn Company Antibacterial 3-(fused-ring substituted)phenyl-5β-amidomethyloxazolidin-2-ones
US5182403A (en) 1988-09-15 1993-01-26 The Upjohn Company Substituted 3(5'indazolyl) oxazolidin-2-ones
ATE201870T1 (de) 1988-09-15 2001-06-15 Upjohn Co 3-(stickstoff substituierte)phenyl-5-beta- amidomethyloxazoliden-2-one
SK283420B6 (sk) 1992-05-08 2003-07-01 Pharmacia & Upjohn Company Antimikrobiálne oxazolidinóny obsahujúce substituované diazínové skupiny
JP3365067B2 (ja) * 1994-02-10 2003-01-08 ソニー株式会社 プラズマ装置およびこれを用いたプラズマ処理方法
DE4425609A1 (de) * 1994-07-20 1996-01-25 Bayer Ag Benzofuranyl- und Benzothienyloxazolidinone
HRP960159A2 (en) 1995-04-21 1997-08-31 Bayer Ag Benzocyclopentane oxazolidinones containing heteroatoms
DE19601264A1 (de) 1996-01-16 1997-07-17 Bayer Ag Pyrido-annellierte Thienyl- und Furanyl-Oxazolidinone
DE19601627A1 (de) 1996-01-18 1997-07-24 Bayer Ag Heteroatomhaltige Cyclopentanopyridyl-Oxazolidinone
DE19604223A1 (de) 1996-02-06 1997-08-07 Bayer Ag Neue substituierte Oxazolidinone
HRP970049A2 (en) 1996-02-06 1998-04-30 Bayer Ag New heteroaryl oxazolidinones
NZ501412A (en) 1997-05-30 2001-11-30 Upjohn Co Oxazolidinone antibacterial agents having a thiocarbonyl functionality
AU729745B2 (en) 1997-07-11 2001-02-08 Pharmacia & Upjohn Company Thiadiazolyl and oxadiazolyl phenyl oxazolidinone antibacterial agents
DE19730847A1 (de) * 1997-07-18 1999-01-28 Bayer Ag Tricyclisch substituierte Oxazolidinone
WO1999012914A1 (fr) 1997-09-11 1999-03-18 Hokuriku Seiyaku Co., Ltd. Derives de thiouree
DE19802235A1 (de) 1998-01-22 1999-07-29 Bayer Ag Mit tricyclischen Indolen substituierte Oxazolidinone
DE19802239A1 (de) 1998-01-22 1999-07-29 Bayer Ag Neue mit Bicyclen substituierte Oxazolidinone
BR9907183A (pt) 1998-01-23 2003-06-10 Versicor Inc Colet neas combinatórias de oxazolidinona, composições e processos de preparação
DE19805117A1 (de) * 1998-02-09 1999-08-12 Bayer Ag Neue Oxazolidinone mit azolhaltigen Tricyclen
JPH11322729A (ja) 1998-03-09 1999-11-24 Hokuriku Seiyaku Co Ltd ジチオカルバミド酸誘導体
JP2000204084A (ja) * 1998-11-11 2000-07-25 Hokuriku Seiyaku Co Ltd チオカルバミド酸誘導体
WO2000029396A1 (de) * 1998-11-17 2000-05-25 Bayer Aktiengesellschaft Neue substituierte phenyloxazolidon-derivate
WO2000029409A1 (de) 1998-11-17 2000-05-25 Bayer Aktiengesellschaft Neue heterocyclyl-substituierte oxazolidon-derivate
EP1200416A1 (en) * 1999-07-28 2002-05-02 Pharmacia & Upjohn Company Oxazolidinones and their use as antiinfectives

Also Published As

Publication number Publication date
CN1367780A (zh) 2002-09-04
NZ516853A (en) 2003-11-28
IL147503A0 (en) 2002-08-14
WO2001009107A1 (en) 2001-02-08
EP1200416A1 (en) 2002-05-02
US6441005B1 (en) 2002-08-27
AU6377900A (en) 2001-02-19
CA2374383A1 (en) 2001-02-08
MXPA02000985A (es) 2002-07-30
US6743811B2 (en) 2004-06-01
BR0012742A (pt) 2002-06-11
KR20020022787A (ko) 2002-03-27
AU773359B2 (en) 2004-05-20
JP2003513885A (ja) 2003-04-15
US20020169191A1 (en) 2002-11-14

Similar Documents

Publication Publication Date Title
AR024968A1 (es) Compuestos de oxazolidinona, metodos de preparacion y composicion que los contiene
WO2002000650A3 (en) Novel compounds possessing antibacterial, antifungal or antitumor activity
DE60330910D1 (de) Verbindungen mit selektiverinhibierender wirkung für gsk3
UY27368A1 (es) Nuevos compuestos
AR018686A1 (es) Compuestos de 1-piperidil benzoimidazol 2-sustituidos como agonistas de receptores orl1, composicion farmaceutica, su uso en medicina, procedimiento de preparacion e intermediarios
MXPA03007249A (es) Compuestos triazolo como inhibidores de mmp.
ATE350108T1 (de) Schweisshemmende zusammensetzungen
ZA919181B (en) Oxazolopyridine derivatives,processes for preparing these and pharmaceutical compositions containing them
UY27336A1 (es) Derivados de 4-piperacinilindol con afinidad receptora de 5-ht6
GEP20063890B (en) Hiv protease inhibitors, compositions containing the same, their pharmaceutical uses and materials for their synthesis
HK1039034A1 (en) Agents for controlling plant pests.
RS49906B (sr) Benzociklohepteni, postupak za njihovo dobijanje, farmaceutski preparati koji ove sadrže kao i njihova primena za izradu lekova
ATE517663T1 (de) Photostabile organische sonnenschutzverbindungen mit antioxidationseigenschaften und daraus gewonnene zusammensetzungen
NO20025641D0 (no) Substituerte 1-aminoalkyl-laktamer og deres anvendelse som muscarin-reseptor-antagonister
AP2004003125A0 (en) Oxo-azabicyclic compounds
IL154964A0 (en) Benzsulfonamide derivatives, their preparation and pharmaceutical compositions containing them
AR015994A1 (es) Derivados de cetolidos 2-halo-6-o-sustituidos, composiciones farmaceuticas que los contienen, su uso para la manufactura de un medicamento y procesos parasu preparacion
EP1634874A4 (en) imidazolidine
AR036176A1 (es) Un derivado de fenil-acetamido-tiazol, un procedimiento para su preparacion, una composicion farmaceutica que lo comprende, un producto o kit que los comprende, y un metodo que utiliza dicho derivado
DK1532098T3 (da) Fremgangsmåde til fremstilling af nitrooxyderivater af naproxen
NO20023251D0 (no) Nye tetrahydropyridiner, fremgangsmåte for deres fremstilling og farmasöytiske preparater inneholdende de samme
EA200100597A2 (ru) Новые 1,1- и 1,2-дизамещенные циклопропановые соединения, способ их получения и содержащие их фармацевтические композиции
AR036056A1 (es) Formulaciones de lactonas y metodos de uso de las mismas
BR0209163A (pt) Composto e processos para preparar um composto
KR910000681A (ko) 신규 화합물

Legal Events

Date Code Title Description
FB Suspension of granting procedure